[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346599-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346599-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","beyond-the-globe-molecular-diagnostics-of-optic-nerve-orbital-and-adnexal-neoplasms","Beyond the Globe - Molecular Diagnostics of Optic Nerve, Orbital, and Adnexal Neoplasms","","Recent advances in molecular pathology have reshaped diagnosis and management of human cancer by combining genomic and epigenomic data with conventional histopathology. High-throughput platforms, including next-generation sequencing, gene fusion panels, and methylation arrays, enable use with formalin-fixed tissue and simultaneous assessment of multiple tumor-defining alterations. The review details key molecular drivers across optic nerve gliomas, optic nerve sheath/orbital meningiomas, orbital mesenchymal tumors, and lacrimal gland neoplasms, emphasizing improved classification, prognostication, and identification of therapeutic targets.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/beyond-the-globe-molecular-diagnostics-of-optic-nerve-orbital-and-adnexal-neoplasms/346599/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/beyond-the-globe-molecular-diagnostics-of-optic-nerve-orbital-and-adnexal-neoplasms/346599.png","ImageObject",300,407,{"name":42,"@type":43},"Ava Thompson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How do high-throughput molecular techniques improve diagnosis in ocular tumors?","Question",{"text":63,"@type":64},"They expand applicability to formalin-fixed tissue and enable simultaneous evaluation of multiple cancer-defining alterations, improving classification and prognostic assessment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What molecular features are highlighted for optic nerve gliomas?",{"text":68,"@type":64},"The review emphasizes MAPK pathway activation through BRAF or FGFR1 alterations, or NF1 inactivation, linking these biological features to diagnostic implications.",{"name":70,"@type":61,"acceptedAnswer":71},"How do molecular diagnostics contribute to distinguishing lacrimal gland neoplasms?",{"text":72,"@type":64},"They help parallel salivary gland counterparts by using recurrent gene fusions (e.g., PLAG1, HMGA2, and MYB::NFIB) to improve diagnostic utility and classification.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346599,1790167261,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":33,"preview_urls":145},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","Review  \nBeyond the Globe: Molecular Diagnostics of Optic Nerve, Orbital, and Adnexal Neoplasms  \nAmanda Dankberg 1,*, Guanqiao Yu 1,*, and Fausto J. Rodriguez 1  \n1 Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA  \nCorrespondence: Fausto J. Rodriguez, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave, Los Angeles, CA 90095, USA. e-mail:  \n[Fjrodriguez@mednet.ucla.edu](Fjrodriguez@mednet.ucla.edu)  \nReceived: September 3, 2025  \nAccepted: January 14, 2026  \nPublished: March 2, 2026  \nKeywords: optic nerve; glioma; meningioma; orbit; lacrimal gland  \nCitation: Dankberg A, Yu G, Rodriguez FJ. Beyond the globe:  \nMolecular diagnostics of optic nerve, orbital, and adnexal neoplasms. Transl Vis Sci Technol. 2026;15(3):3, [https://doi.org/10.1167/tvst.15.3.3](https://doi.org/10.1167/tvst.15.3.3)  \nRecent advances in molecular pathology have transformed the diagnostic landscape and management of human cancer. Increasingly, integration of genomic and epigenomic data with conventional histopathology has improved tumor classification, refined prognostic assessment, and revealed previously unsuspected therapeutic targets. Highthroughput techniques such as next-generation sequencing, gene fusion panels, and methylation arrays have expanded applicability to formalin-fixed tissue and enabled simultaneous evaluation of multiple cancer-defining alterations/genetic drivers. In optic nerve gliomas, MAPK pathway activation through BRAF or FGFR1 alterations, or NF1 inactivation, is a basic biological feature with diagnostic implications, while MEK inhibitors may be of clinical benefit in selected patients. Optic nerve sheath/orbital meningiomas demonstrate divergent molecular landscapes depending on location, with NF2-driven and non–NF2-driven pathways informing recurrence risk and behavior. In the orbit, characteristic genetic drivers facilitate diagnosis of mesenchymal tumors such as solitary fibrous tumor (NAB2::STAT6) and alveolar rhabdomyosarcoma (PAX3/7::FOXO1), while molecular profiling assists in distinguishing challenging peripheral nerve and melanocytic lesions. Similarly, lacrimal gland neoplasms parallel salivary gland counterparts, with recurrent fusions such as PLAG1, HMGA2, and MYB::NFIB of great diagnostic utility. These advances underscore the growing role of molecular diagnostics in improving accuracy, guiding prognostication, and refining the classification of rare ocular tumors. As high-throughput techniques continue to mature, integration with evolving spatial and single-cell–based approaches promises to expand our understanding and further personalize diagnostic and therapeutic strategies.  \nIntroduction  \nNumerous advances in the diagnosis and classification of tumors of the eye and ocular adnexa have occurred, as with cancers at many other sites. A fifth edition of Eye and Orbit Tumours has been published 1 and, in the spirit of other World Health Organization (WHO) Classifications, started incorporating genetic information into diagnostic approaches.2 , 3 Genetic drivers of many primary tumors have been increasingly clarified. These advances have been the consequence, in part, of The Cancer Genome Atlas and numerous high-throughput molecular studies undertaken in every major category of tumors. A variety of platforms and techniques with increasing applicability to formalin-fixed, paraffin-embedded material, including methylation-based arrays, next-generation  \nsequencing (NGS), and gene expression profiling, have become important tools for integrating molecular data into traditional diagnostic approaches for a variety of tumor types. Methylation arrays, in particular, have found increased applications in the diagnostic approach to brain tumors, soft tissue, head and neck, and other tumors and have facilitated the identification and characteriz","cbCaihsRJG4nKJm9","https://ap.wps.com/l/cbCaihsRJG4nKJm9","pdf",5894131,12,"English","# Introduction\n# Special Techniques\n## Targeted molecular assays and their limitations\n# Molecular drivers by tumor type\n## Optic nerve gliomas\n## Optic nerve sheath/orbital meningiomas\n## Orbit: mesenchymal and peripheral nerve/melanocytic lesions\n## Lacrimal gland neoplasms","[{\"question\":\"How do high-throughput molecular techniques improve diagnosis in ocular tumors?\",\"answer\":\"They expand applicability to formalin-fixed tissue and enable simultaneous evaluation of multiple cancer-defining alterations, improving classification and prognostic assessment.\"},{\"question\":\"What molecular features are highlighted for optic nerve gliomas?\",\"answer\":\"The review emphasizes MAPK pathway activation through BRAF or FGFR1 alterations, or NF1 inactivation, linking these biological features to diagnostic implications.\"},{\"question\":\"How do molecular diagnostics contribute to distinguishing lacrimal gland neoplasms?\",\"answer\":\"They help parallel salivary gland counterparts by using recurrent gene fusions (e.g., PLAG1, HMGA2, and MYB::NFIB) to improve diagnostic utility and classification.\"}]","Beyond the Globe - Molecular Diagnostics of Optic Nerve, Orbital, and Adnexal Neoplasms | PDF",1790062096,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a07f8b5e71ff6ef82e0f026e1ef8277c.webp",983,1272,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/95c93dfe513d95a286c36d525942e23b.webp",982,1270,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47f403a532d53d8c80ec41df57a5fdac.webp",981,1269,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a561b1e6b4cba1b88cb5491393eecda7.webp",980,1268]